Bristol-Myers Squibb Company (BRM)
XETR
Closed
Aug 25, 2026
Day's Range
57.2452 wk Range
36.60Overview - BRM - Bristol-Myers Squibb Company
Key Statistics
Valuation
Enterprise Value
129.91B
P/E (Trailing)
‪14.85‬
PEG Ratio
‪0.09‬
Price / Sales (TTM)
‪2.39‬
Price / Book
‪6.16‬
EV / EBITDA
‪8.01‬
Profitability
Gross Margin
‪71.27%‬
Profit Margin
‪18.87%‬
Operating Margin
‪34.41%‬
Return on Assets
‪10.71%‬
Return on Equity
‪46.59%‬
Ownership
Shares Outstanding
2.04B
Float
2.03B
Held by Insiders
‪0.09%‬
Held by Institutions
‪84.68%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪52.70‬
200-Day Avg
‪49.49‬
Dividends
Payout Ratio
‪55.29%‬
Frequency
Quarterly
Peers - BRM - Bristol-Myers Squibb Company
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XETR.
- BRMXETRBristol-Myers Squibb Company114.04BMarket Cap+29.05%52-week change14.21P/E (Trailing)‪18.87%‬Profit Margin
- LLYXETREli Lilly and Company947.86BMarket Cap+41.68%52-week change41.67P/E (Trailing)‪33.52%‬Profit Margin
- JNJXETRJohnson & Johnson558.37BMarket Cap+35.35%52-week change31.54P/E (Trailing)‪21.48%‬Profit Margin
- 4ABXETRAbbVie Inc.403.60BMarket Cap+22.07%52-week change74.62P/E (Trailing)‪9.80%‬Profit Margin
- RHOXETRRoche Holding AG323.00BMarket Cap+28.42%52-week change24.39P/E (Trailing)‪19.60%‬Profit Margin
- 6MKXETRMerck & Co., Inc.318.95BMarket Cap+43.83%52-week change123.92P/E (Trailing)‪4.76%‬Profit Margin
- NOTXETRNovartis AG257.47BMarket Cap+20.27%52-week change24.04P/E (Trailing)‪22.50%‬Profit Margin
Profile Summary - BRM - Bristol-Myers Squibb Company
About
Bristol-Myers Squibb Company is a global biopharmaceutical company focused on discovering, developing, licensing, manufacturing, and commercializing medicines for serious diseases. Bristol-Myers Squibb Company’s portfolio spans oncology, hematology, immunology, cardiovascular disease, and neuroscience, with products…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
